Clinical trial
Cohort of Patients With Covid19: Constitution of Blood Samples Collections With Clinical Characterization
Name
COVIGENET
Description
Biological collection (blood sample) associated with clinical data from Covid-19 patients
Trial arms
Trial start
2020-05-31
Estimated PCD
2023-05-31
Trial end
2023-05-31
Status
Terminated
Treatment
Biological test
Blood sample
Arms:
Collection of blood sample
Size
500
Primary endpoint
Phenotype/genotype correlation research modulating the severity of Covid-19 disease
Anytime in the period of 10 years
Eligibility criteria
Inclusion Criteria:
* Diagnosis of COVID-19 confirmed on RT-PCR test or chest scanner
* Any age
* Membership in the general social security system
* Inform consent signed by the patient or by legal representatives for minors
Exclusion Criteria:
* Refusal of the patient or one of the legal representatives
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'interventionModelDescription': 'Collection of blood samples in a cohort of Covid-19 patients', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 500, 'type': 'ACTUAL'}}
Updated at
2024-04-12
1 organization
1 product
1 indication
Organization
Centre Hospitalier Intercommunal CréteilProduct
Biological testIndication
COVID-19